UNITED THERAPEUTICS Corp — Director's Dealing 2014

Apr 18, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: UNITED THERAPEUTICS Corp (UTHR)
CIK: 0001082554
Period of Report: 2014-04-17

Reporting Person: ROTHBLATT MARTINE A (Director, CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2014-04-17	Common Stock	M	3833	$34.56	Acquired	3973	Direct
2014-04-17	Common Stock	S	3833	$99.5931	Disposed	140	Direct
2014-04-17	Common Stock	M	5233	$30.75	Acquired	5373	Direct
2014-04-17	Common Stock	S	2933	$96.9271	Disposed	2440	Direct
2014-04-17	Common Stock	S	1100	$98.0973	Disposed	1340	Direct
2014-04-17	Common Stock	S	1000	$98.925	Disposed	340	Direct
2014-04-17	Common Stock	S	200	$99.76	Disposed	140	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-04-17	Stock Options	$34.56	M	3833	Disposed	2015-12-30	Common Stock (3833)	Direct
2014-04-17	Stock Options	$30.75	M	5233	Disposed	2017-12-31	Common Stock (5233)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	166	Indirect
Common Stock	533094.05	Indirect

Footnotes

F1: This exercise of stock options and corresponding sale of shares was pursuant to a Rule 10b5-1 trading plan entered into by the reporting person.

F2: Exercise price and number of shares/awards has been adjusted to reflect the issuer's two-for-one stock split on September 22, 2009.

F3: This transaction was executed in multiple trades at prices ranging from $98.7301 to $99.87. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F4: This transaction was executed in multiple trades at prices ranging from $96.58 to $97.55. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F5: This transaction was executed in multiple trades at prices ranging from $97.58 to $98.56. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F6: This transaction was executed in multiple trades at prices ranging from $98.72 to $99.50. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

F7: This transaction was executed in multiple trades at prices ranging from $99.73 to $99.79. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.